7. 徳永勝人、松沢佑次、小谷一晃、他：種々の合併症を考慮した理想体重、第9日本肥満学会記録1998;236-238.
8. 村上正人、松野俊夫、中村延江、他：健常人のストレス状態に関する研究―ストレスによる症状のあらわれ方とその対策について―、心身医療1989; 1: 72-82
9. Sakane N, Yoshida T, Umekawa T, et al: β3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and insulin resistance syndrome. Diabetologia 1997; 40: 200-204.
10. 山田信博：高インスリン血症と虚血性心疾患の危険因子との相関、糖尿病脂質代謝研究会記録1993; 9: 9.
11. 板倉弘重：日本人に Syndrome X は存在するか、1994; 5: 747-752.
12. Sakane N, Yoshida T, Yoshioka K, et al: β3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes 1997;46:1633-1636.
13. Sakane N,Yoshida T,Yoshioka K,et al: Trp64Arg mutation of β3-adrenoceptor gene is associated with diabetic nephropathy in NIDDM. Diabetologia 1998; 41: 1533-1534.
14. Sakane N, Yoshida T, Yoshioka K, et al: Genetic variation in the β3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 1996; 19: 1034-1035.
15. Yoshida T, Sakane N, Umekawa T, et al: Mutation of β3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995; 346: 1433-1434.
16. Umekawa T, Yoshida T, Sakane N, et al: Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes. Diabetes 1999; 48: 117-120.
17. Sakane N, Yoshida T, Umekawa T, et al: Effects of Trp64Arg mutation in the β3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997; 20,1887-1890.
